(FXH) First Trust Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US33734X1431 • Health
FXH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices
The First Trust Health Care AlphaDEX® Fund (FXH) is an exchange-traded fund (ETF) listed on the NYSE ARCA. It is designed to provide exposure to the healthcare sector by tracking the performance of the AlphaDEX® Health Care Index.
The fund employs a rules-based, quantitative approach to select its holdings. It utilizes the AlphaDEX® selection methodology, which evaluates stocks based on factors such as price appreciation, revenue growth, and other metrics. This methodology aims to identify companies with the potential to outperform traditional market capitalization-weighted indices.
FXH focuses on the healthcare sector, which includes companies involved in healthcare equipment, biotechnology, pharmaceuticals, and other related industries. The funds strategy is to invest in stocks that are part of the Russell 1000® Index, a widely followed index of large-cap U.S. companies.
As of the latest data, the fund has approximately $1.05 billion in assets under management (AUM). It is structured as an ETF, offering investors the ability to gain exposure to a diversified portfolio of healthcare stocks through a single investment vehicle.
For more information about the fund, including its full holdings, performance, and investment objectives, investors can visit the First Trust website at http://www.ftportfolios.com/.
Additional Sources for FXH ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FXH ETF Overview
Market Cap in USD | 899m |
Category | Health |
TER | 0.62% |
IPO / Inception | 2007-05-08 |
FXH ETF Ratings
Growth Rating | 9.06 |
Fundamental | - |
Dividend Rating | 31.0 |
Rel. Strength | -12.4 |
Analysts | - |
Fair Price Momentum | 88.37 USD |
Fair Price DCF | - |
FXH Dividends
Dividend Yield 12m | 0.38% |
Yield on Cost 5y | 0.47% |
Annual Growth 5y | 24.75% |
Payout Consistency | 38.0% |
FXH Growth Ratios
Growth Correlation 3m | -91.4% |
Growth Correlation 12m | 9.2% |
Growth Correlation 5y | 4% |
CAGR 5y | 3.09% |
CAGR/Max DD 5y | 0.10 |
Sharpe Ratio 12m | 0.08 |
Alpha | -12.37 |
Beta | 0.860 |
Volatility | 29.77% |
Current Volume | 79.7k |
Average Volume 20d | 24.4k |
As of April 16, 2025, the stock is trading at USD 97.23 with a total of 79,715 shares traded.
Over the past week, the price has changed by +3.83%, over one month by -7.84%, over three months by -9.42% and over the past year by -5.47%.
Neither. Based on ValueRay Analyses, First Trust Health Care is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 9.06 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FXH as of April 2025 is 88.37. This means that FXH is currently overvalued and has a potential downside of -9.11%.
First Trust Health Care has no consensus analysts rating.
According to ValueRays Forecast Model, FXH First Trust Health Care will be worth about 97.7 in April 2026. The stock is currently trading at 97.23. This means that the stock has a potential upside of +0.5%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 97.7 | 0.5% |